Through
1/1
Coronavirus Research
In the U.S., COVID-19 wasn’t sole cause of excess deaths in 2020
In the U.S., COVID-19 wasn’t sole cause of excess deaths in 2020
Comparing death rates in the United States with those of the five biggest European countries, Penn and Max Planck demographers found that significant excess mortality cost more lives annually than the epidemic itself.
Understanding and addressing barriers to COVID vaccine acceptance
Understanding and addressing barriers to COVID vaccine acceptance
Different communities have different reasons for wanting to wait on this shot. Getting to the heart of those concerns can help meet people where they are.
Hormone drugs may disarm COVID-19 spike protein and stop disease progression
Hormone drugs may disarm COVID-19 spike protein and stop disease progression
Hormone drugs that reduce androgen levels may help disarm the coronavirus spike protein used to infect cells and stop the progression of severe COVID-19 disease, suggests a new preclinical study.
‘Research at Penn’ showcases University breakthroughs and innovations
‘Research at Penn’ showcases University breakthroughs and innovations
Produced by the Provost’s Office, the brochure highlights groundbreaking research from each of Penn’s 12 schools. This year it is online-only.
Immune response in some children may influence COVID treatments for adults
Immune response in some children may influence COVID treatments for adults
A joint study from researchers at Penn and the Children’s Hospital of Philadelphia shows that T cell activation in children with multisystem inflammatory syndrome is more similar to adults with severe COVID-19.
When the message matters, use science to craft it
When the message matters, use science to craft it
An interdisciplinary initiative called the Message Effects Lab aims to understand, tap into, and develop communication around what motivates specific behaviors for specific populations. Its first projects center around COVID-19 testing and vaccines.
Antibodies to common cold coronaviruses do not protect against SARS-CoV-2
Antibodies to common cold coronaviruses do not protect against SARS-CoV-2
Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 are common in the population but don’t neutralize the COVID-19-causing virus.
An ‘electronic nose’ to sniff out COVID-19
An ‘electronic nose’ to sniff out COVID-19
Through a newly funded grant, researchers across the University are developing a device that can rapidly detect COVID-19 based on the disease’s unique odor profile.
Pregnant mothers’ antibodies to SARS-CoV-2 transfer to their fetuses
Pregnant mothers’ antibodies to SARS-CoV-2 transfer to their fetuses
Antibodies to coronavirus in pregnant women cross the placenta efficiently, and are found at similar concentrations in their newborns, according to a large study from researchers at the Perelman School of Medicine.
Patients in cancer remission at high risk for severe COVID-19 illness
Patients in cancer remission at high risk for severe COVID-19 illness
Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, with Black cancer patients twice as likely to test positive for the virus.
In the News
Technical.ly Philly
What a new innovation index tells us about Philadelphia
Penn is lauded for its research and development efforts, including the modified mRNA technique that was commercialized into a COVID vaccine and won its researchers a Nobel Prize last year.
FULL STORY →
The New York Times
This may be the most overlooked COVID symptom
Ken Cadwell of the Perelman School of Medicine studies how COVID affects the gut and explains you will feel the illness in other parts of your body and not just your lungs.
FULL STORY →
CBS News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Minnesota Public Radio
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Philadelphia Inquirer
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Boston Globe
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →